Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US
Abstract
:1. Introduction
2. Disproportionate Impact of Coronavirus Disease 2019 (COVID-19) on Minority Communities in the US
3. Clinical Risk Factors for COVID-19 Acquisition and Adverse Disease That Are Disproportionate among Minority Populations in the US
3.1. Diabetes and COVID-19 Patients
3.2. Hypertension and COVID-19 Patients
3.3. Cardiovascular Disease and COVID-19 Patients
3.4. Pulmonary Disease and COVID-19
4. Interventions to Mitigate Clinical Factors Contributing to COVID-19 Morbidity and Mortality among Minority Populations in the US
4.1. Diabetes and COVID-19 Mitigation Strategies
4.2. Hypertension and COVID-19 Mitigation Strategies
4.3. Cardiovascular Disease and COVID-19 Mitigation Strategies
4.4. Chronic Obstructive Pulmonary Disease and COVID-19 Mitigation Strategies for Underserved Populations
5. Policy Changes to Combat Health Inequities during COVID-19 Crisis and Beyond
6. Practices That May Enhance the Effectiveness of Clinicians When They Engage Disparity Populations
7. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Bassetti, M.; Vena, A.; Giacobbe, D.R. The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm. Eur. J. Clin. Investig. 2020, 50. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lai, C.-C.; Shih, T.-P.; Ko, W.-C.; Tang, H.-J.; Hsueh, P.-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int. J. Antimicrob. Agents 2020, 55, 105924. [Google Scholar] [CrossRef] [PubMed]
- Li, Q.; Guan, X.; Wu, P.; Wang, X.; Zhou, L.; Tong, Y.; Ren, R.; Leung, K.S.M.; Lau, E.H.Y.; Wong, J.Y.; et al. Faculty Opinions recommendation of Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. Faculty Opinions—Post-Publication Peer Review of the Biomedical Literature. N. Engl. J. Med. 2020, 382, 1199–1207. [Google Scholar] [CrossRef] [PubMed]
- Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020, 395, 497–506. [Google Scholar] [CrossRef] [Green Version]
- Woo, P.C.; Lau, S.K.P.; Lam, C.S.F.; Lau, C.C.Y.; Tsang, A.K.L.; Lau, J.H.N.; Bai, R.; Teng, J.L.L.; Tsang, C.C.C.; Wang, M.; et al. Discovery of Seven Novel Mammalian and Avian Coronaviruses in the Genus Deltacoronavirus Supports Bat Coronaviruses as the Gene Source of Alphacoronavirus and Betacoronavirus and Avian Coronaviruses as the Gene Source of Gammacoronavirus and Deltacoronavirus. J. Virol. 2012, 86, 3995–4008. [Google Scholar] [CrossRef] [Green Version]
- Chairez, R.; Hollinger, B.; Melnick, J.L.; Dreesman, G.R.; Ghendon, Y.; Porubel, L.; Sasaki, Y.; Sasaki, R.; Cohen, G.H.; Pizer, L.I.; et al. International Committee on Taxonomy of Viruses. Virus Taxonomy: 2017 Release. Available online: https://talk.ictvonline.org/taxonomy/ (accessed on 13 October 2017).
- Du Toit, A. Outbreak of a novel coronavirus. Nat. Rev. Genet. 2020, 18, 123. [Google Scholar] [CrossRef]
- Rothan, H.A.; Byrareddy, S. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J. Autoimmun. 2020, 109, 102433. [Google Scholar] [CrossRef]
- Chan, J.; To, K.K.W.; Tse, H.; **, D.-Y.; Yuen, K.-Y. Interspecies transmission and emergence of novel viruses: Lessons from bats and birds. Trends Microbiol. 2013, 21, 544–555. [Google Scholar] [CrossRef]
- Hui, D.S.; Azhar, E.E.; Madani, T.A.; Ntoumi, F.; Kock, R.; Dar, O.; Ippolito, G.; McHugh, T.D.; Memish, Z.A.; Drosten, C.; et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China. Int. J. Infect. Dis. 2020, 91, 264–266. [Google Scholar] [CrossRef] [Green Version]
- Fehr, A.R.; Perlman, S. Coronaviruses: An Overview of Their Replication and Pathogenesis. Methods Mol. Biol. 2015, 1282, 1–23. [Google Scholar] [CrossRef] [Green Version]
- Weiss, S.R.; Navas-Martin, S. Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus. Microbiol. Mol. Boil. Rev. 2005, 69, 635–664. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Letko, M.C.; Marzi, A.; Munster, V.J. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat. Microbiol. 2020, 5, 562–569. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Woo, P.C.Y.; Lau, S.K.P.; Chu, C.; Chan, K.-H.; Tsoi, H.-W.; Huang, Y.; Wong, B.H.L.; Poon, R.W.S.; Cai, J.J.; Luk, W.-K.; et al. Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia. J. Virol. 2005, 79, 884–895. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chan, J.; Lau, S.K.P.; To, K.K.-W.; Cheng, V.C.C.; Woo, P.C.; Yuen, K.-Y. Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease. Clin. Microbiol. Rev. 2015, 28, 465–522. [Google Scholar] [CrossRef] [Green Version]
- Cheng, V.C.C.; Lau, S.K.P.; Woo, P.C.Y.; Yuen, K.-Y. Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection. Clin. Microbiol. Rev. 2007, 20, 660–694. [Google Scholar] [CrossRef] [Green Version]
- Zhong, N.S.; Zheng, B.J.; Li, Y.M.; Poon, L.L.M.; ** Hypertension in Middle-aged Women and Men. JAMA 2002, 287, 1003–1010. [Google Scholar] [CrossRef]
- Jean, S.S.; Lee, P.; Hsueh, P.R. Treatment Options for COVID-19: The Reality and Challenges Review. J. Microbiol. Immunol. Infect. 2020, 3, 436–443. [Google Scholar] [CrossRef]
- Bimonte, S.; Crispo, A.; Amore, A.; Celentano, E.; Cuomo, A.; Cascella, M. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research (Suppl.3). In Vivo 2020, 34, 1597–1602. [Google Scholar] [CrossRef]
- Maddocks, M.; Lovell, N.; Booth, S.; Man, W.D.-C.; Higginson, I. Palliative care and management of troublesome symptoms for people with chronic obstructive pulmonary disease. Lancet 2017, 390, 988–1002. [Google Scholar] [CrossRef] [Green Version]
© 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Alcendor, D.J. Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US. J. Clin. Med. 2020, 9, 2442. https://doi.org/10.3390/jcm9082442
Alcendor DJ. Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US. Journal of Clinical Medicine. 2020; 9(8):2442. https://doi.org/10.3390/jcm9082442
Chicago/Turabian StyleAlcendor, Donald J. 2020. "Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US" Journal of Clinical Medicine 9, no. 8: 2442. https://doi.org/10.3390/jcm9082442